Urania Dafni
National and Kapodistrian University of Athens
H-index: 65
Europe-Greece
Top articles of Urania Dafni
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub … | Breast Cancer Research and Treatment | Diogo Martins-Branco Marie Kassapian Véronique Debien Rafael Caparica Daniel Eiger | 2024/2 |
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion–Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real … | JCO Precision Oncology | Allan Hackshaw Otto Fajardo Urania Dafni Hans Gelderblom Pilar Garrido | 2024/1 |
12P Atezolizumab plus bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance: Final results from the randomised, non-comparative phase II ETOP ABC-lung trial | ESMO Open | M Frueh RA Soo A Vervita BC Cho M Majem | 2024/3/1 |
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol | Clinical and Translational Radiation Oncology | Rémy Kinj Olivier Gaide Wendy Jeanneret-Sozzi Urania Dafni Stéphanie Viguet-Carrin | 2024/2/8 |
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma | Science Immunology | David Barras Eleonora Ghisoni Johanna Chiffelle Angela Orcurto Julien Dagher | 2024/2/2 |
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines | G Zarkavelis AL Amylidi C Verbaanderd NI Cherny Y Metaxas | 2023/2/1 | |
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS: H) version 1.0 | Annals of Oncology | B Kiesewetter U Dafni EGE de Vries Jorge Barriuso G Curigliano | 2023/9/1 |
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma | Journal for Immunotherapy of Cancer | Krisztian Homicsko Panagiota Zygoura Maxim Norkin Stephanie Tissot Nicholas Shakarishvili | 2023 |
PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS: H) VERSION 1.0 | HemaSphere | Barbara Kiesewetter Urania Dafni Elisabeth GE De Vries Jorge Barriuso Giuseppe Curigliano | 2023/8/1 |
120MO Adjuvant pembrolizumab versus placebo for early-stage NSCLC after resection and optional chemotherapy: Updated results from PEARLS/KEYNOTE-091 | Immuno-Oncology and Technology | B Besse L Havel S Peters SI Marreaud N Jha | 2023/12/1 |
Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma | bioRxiv | Johanna Chiffelle David Barras Remy Petremand Angela Orcurto Sara Bobisse | 2023 |
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases | ESMO open | Pierre Martin Zoi Tsourti Joana Ribeiro Luis Castelo-Branco Evandro de Azambuja | 2023/6/1 |
ESMO guidance for reporting oncology real-world evidence (GROW) | ESMO Real World Data and Digital Oncology | L Castelo-Branco A Pellat D Martins-Branco Antonis Valachis JWG Derksen | 2023/11/1 |
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial | Lung Cancer | Solange Peters Igor Letovanec Murielle Mauer Urania Dafni Dunson Ejedepang | 2023/1/1 |
191P ROS1 fusions in resected stage I-III adenocarcinoma (ADC): A Lungscape ETOP study | Journal of Thoracic Oncology | EJ M Speel T Radonic U Dafni E Thunnissen JH Rüschoff | 2023/4/1 |
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer | Nature Cancer | Sara Bobisse Valentina Bianchi Janos L Tanyi Apostolos Sarivalasis Edoardo Missiaglia | 2023/10 |
16MO Clinical impact of plasma EGFR analysis: Results from the ETOP-BOOSTER randomized phase II trial | Journal of Thoracic Oncology | RA Soo U Dafni JY Han BC Cho E Nadal | 2023/4/1 |
European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European … | Journal of Thoracic Oncology | Isabelle Opitz Andrea Bille Urania Dafni Kristiaan Nackaerts Luca Ampollini | 2023/9/1 |
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated … | Annals of Oncology | L Paz-Ares MER O'Brien M Mauer U Dafni K Oselin | 2022/4/1 |
EORTC-1416-LCG/ETOP 8-15–PEARLS/KEYNOTE-091 study of pembrolizumab versus placebo for completely resected early-stage non-small cell lung cancer (NSCLC): outcomes in subgroups … | Mary ER O'Brien Luis Paz-Ares Nitish Jha Urania Dafni Kersti Oselin | 2022/6/1 |
